PharmaShots | Incisive News in 3 Shots

Subscribe Now

actuate therapeutics

Actuate Therapeutics’ Elraglusib Receives the US FDA’s Rare Pediatric Disease Designation for Treating Ewing Sarcoma

Actuate Therapeutics’ Elraglusib Receives the US FDA’s Rare Pediatric Disease Designation for Treating Ewing Sarcoma

November 14, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us